InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Oliver Tracie. Officer active across 1 company, notably Arrowhead Pharmaceuticals, INC.. Aggregated, 4 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €510k. History available since 4 January 2023. The latest transaction was disclosed on 2 July 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Oliver Tracie is a declarant linked to Arrowhead Pharmaceuticals, INC. (XNAS), where he is Chief Commercial Officer. Across 4 filings in total, the 4 sampled filings run from 2023-01-05 to 2024-07-03 and show €509718 of sales, with no purchases reported.